Triple

T15983589
Position Surface form Disambiguated ID Type / Status
Subject European Pharmacopoeia E387634 entity
Predicate isMaintainedBy P86 FINISHED
Object European Pharmacopoeia Commission
The European Pharmacopoeia Commission is the decision-making body responsible for setting and updating official quality standards for medicines and their ingredients across member states of the Council of Europe.
E387634 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Pharmacopoeia Commission | Statement: [European Pharmacopoeia, isMaintainedBy, European Pharmacopoeia Commission]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Pharmacopoeia Commission
Context triple: [European Pharmacopoeia, isMaintainedBy, European Pharmacopoeia Commission]
  • A. European Pharmacopoeia
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: European Pharmacopoeia Commission
Triple: [European Pharmacopoeia, isMaintainedBy, European Pharmacopoeia Commission]
Generated description
The European Pharmacopoeia Commission is the decision-making body responsible for setting and updating official quality standards for medicines and their ingredients across member states of the Council of Europe.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: European Pharmacopoeia Commission
Target entity description: The European Pharmacopoeia Commission is the decision-making body responsible for setting and updating official quality standards for medicines and their ingredients across member states of the Council of Europe.
  • A. European Pharmacopoeia chosen
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e15756d6488190ac35da00e96ce21d completed April 16, 2026, 9:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3cdf7848190848e9081027dc027 completed May 9, 2026, 11:31 p.m.
NEDg Description generation batch_69ffc5669c1c81909bacf61c96cb7816 completed May 9, 2026, 11:38 p.m.
NED2 Entity disambiguation (via description) batch_69ffc5c7db1c8190b4e1de6f6e3ce8a0 completed May 9, 2026, 11:39 p.m.
Created at: April 10, 2026, 4:54 a.m.